Cardeon Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Cardeon General Information

Description

Developer of therapeutic drugs cardiac surgery patients. The company engages in research and development of therapeutic drugs fot the treatment of cardiac patients.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 10600 North Tantau Avenue
  • Cupertino, CA 95014
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardeon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2011 0000 Completed Generating Revenue
1. Later Stage VC (Series D) 01-Dec-2001 0000 0000 Completed Generating Revenue
To view Cardeon’s complete valuation and funding history, request access »

Cardeon Board Members (3)

Name Representing Role Since
Wende Hutton Self Board Member 000 0000
To view Cardeon’s complete board members history, request access »

Cardeon Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ABS Ventures Venture Capital Minority 000 0000 000000 0
Apax Partners PE/Buyout Minority 000 0000 000000 0
Delphi Ventures Venture Capital Minority 000 0000 000000 0
Mayfield Fund Venture Capital Minority 000 0000 000000 0
To view Cardeon’s complete investors history, request access »